Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists
Data up to Jan 2025
Total Citations Per Year
Abstract
References (91)
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
1998 • 1,575 citations
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
1989 • 1,313 citations
Muscarinic Receptors—Characterization, coupling and function
1993 • 1,264 citations
Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding
1996 • 1,143 citations
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
1997 • 1,142 citations
Two functional components of the hippocampal memory system
1994 • 1,114 citations
Neuropsychological Deficits in Neuroleptic Naive Patients With First-Episode Schizophrenia
1994 • 1,099 citations
Prevalence of smoking among psychiatric outpatients
1986 • 1,059 citations
A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's Disease
1994 • 953 citations
A 5-month, randomized, placebo-controlled trial of galantamine in AD
2000 • 911 citations
Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies
1991 • 903 citations
Donepezil Improves Cognition and Global Function in Alzheimer Disease<subtitle>A 15-Week, Double-blind, Placebo-Controlled Study</subtitle>
1998 • 753 citations
Hepatotoxic Effects of Tacrine Administration in Patients With Alzheimer's Disease
1994 • 736 citations
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
1993 • 689 citations
Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia
1995 • 676 citations
Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease
1997 • 625 citations
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
2001 • 622 citations
Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice
2002 • 531 citations
Human Serial Learning: Enhancement with Arecholine and Choline Impairment with Scopolamine
1978 • 530 citations
Comparative effects of cholinergic drugs and lesions of nucleus basalis or fimbria-fornix on delayed matching in rats
1985 • 493 citations
Physostigmine: Improvement of Long-Term Memory Processes in Normal Humans
1978 • 442 citations
Acetylcholine Activates an α-Bungarotoxin-Sensitive Nicotinic Current in Rat Hippocampal Interneurons, But Not Pyramidal Cells
1998 • 380 citations
Abnormal Regulation of High Affinity Nicotinic Receptors in Subjects with Schizophrenia
2000 • 340 citations
Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
2003 • 325 citations
Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat: further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes
1989 • 325 citations
Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of alzheimer's disease
1998 • 313 citations
Essential role of neocortical acetylcholine in spatial memory
1995 • 310 citations
Memory impairment in schizophrenia: its extent, affiliations and neuropsychological character
1992 • 303 citations
Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task
1992 • 282 citations
Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells.
1992 • 271 citations
Selective α 7 -nicotinic agonists normalize inhibition of auditory response in DBA mice
1998 • 268 citations
Cholinergic gating of response to auditory stimuli in rat hippocampus
1992 • 264 citations
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice
2001 • 254 citations
Atypical, but Not Typical, Antipsychotic Drugs Increase Cortical Acetylcholine Release without an Effect in the Nucleus Accumbens or Striatum
2002 • 249 citations
Effects of Cigarette Smoking and Nicotine Nasal Spray on Psychiatric Symptoms and Cognition In Schizophrenia
2002 • 245 citations
Nucleus basalis magnocellularis and medial septal area lesions differentially impair temporal memory
1987 • 242 citations
Upregulation of surface alpha4beta2 nicotinic receptors is initiated by receptor desensitization after chronic exposure to nicotine.
1999 • 238 citations
The effects of physostigmine and scopolamine on recognition memory in monkeys
1986 • 224 citations
Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands.
1996 • 222 citations
Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease
1995 • 221 citations
Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation
2000 • 219 citations
Low Muscarinic Receptor Binding in Prefrontal Cortex From Subjects With Schizophrenia: A Study of Brodmann’s Areas 8, 9, 10, and 46 and the Effects of Neuroleptic Drug Treatment
2001 • 219 citations
Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA- and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats: Differential dependence on cholinergic neuronal loss
1991 • 210 citations
Physostigmine and Recent Memory: Effects in Young and Aged Nonhuman Primates
1979 • 205 citations
In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia
2002 • 204 citations
Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21
1995 • 203 citations
Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia
2002 • 196 citations
Functional Characterization of the Novel Neuronal Nicotinic Acetylcholine Receptor Ligand GTS-21 In Vitro and In Vivo
1997 • 194 citations
m1–m5 Muscarinic Receptor Distribution in Rat CNS by RT‐PCR and HPLC
1994 • 189 citations
Recall memory deficit in schizophrenia
1989 • 189 citations
Postmortem Studies in Schizophrenia
1998 • 187 citations
A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia
2002 • 169 citations
Desensitization of the nicotine‐induced mesolimbic dopamine responses during constant infusion with nicotine
1995 • 168 citations
Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
1994 • 165 citations
Removal of the hippocampus and transection of the fornix produce comparable deficits on delayed non-matching to position by rats
1992 • 164 citations
Memory and the septo-hippocampal cholinergic system in the rat
1983 • 156 citations
The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.
1996 • 145 citations
Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine
1987 • 141 citations
Improvement in Smooth Pursuit Eye Movements after Cigarette Smoking in Schizophrenic Patients
1998 • 138 citations
Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease
1996 • 117 citations
The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat.
2001 • 114 citations
Distributions of nicotinic acetylcholine receptor α7 and β2 subunits on cultured hippocampal neurons
1999 • 112 citations
Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes
1989 • 104 citations
An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia
2002 • 99 citations
Inhibition of Acetylcholinesterase Activity in Human Brain Tissue and Erythrocytes by Galanthamine, Physostigmine and Tacrine
1991 • 96 citations
New approach to drug therapy in Alzheimer's dementia Alfred Maelicke and Edson X. Albuquerque
1996 • 92 citations
The Muscarinic M1/M4 Receptor Agonist Xanomeline Exhibits Antipsychotic-Like Activity in Cebus apella Monkeys
2003 • 88 citations
Dependence of nicotinic acetylcholine receptor recovery from desensitization on the duration of agonist exposure.
1999 • 86 citations
Increased hippocampal acetylcholine release during a working memory task
1996 • 81 citations
The Effects of AMPA‐induced Lesions of the Septo‐hippocampal Cholinergic Projection on Aversive Conditioning to Explicit and Contextual Cues and Spatial Learning in the Water Maze
1995 • 66 citations
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry
1999 • 61 citations
Neurochemical effects of the M1 muscarinic agonist xanomeline (LY246708/NNC11-0232).
1994 • 60 citations
Augmenting Atypical Antipsychotics with a Cognitive Enhancer (Donepezil) Improves Regional Brain Activity in Schizophrenia Patients: A Pilot Double-blind Placebo Controlled BOLD fMRI Study
2003 • 57 citations
Beneficial Effect of Donepezil Augmentation for the Management of Comorbid Schizophrenia and Dementia
2003 • 56 citations
Continuous ICV infusion of scopolamine impairs sustained attention of rhesus monkeys
1993 • 56 citations
Increased muscarinic cholinergic receptors in prefrontal cortices of medicated schizophrenics
1983 • 55 citations
Continuous physostigmine infusion in rats with excitotoxic lesions of the nucleus basalis magnocellularis: effects on performance in the water maze task and cortical cholinergic markers.
1989 • 53 citations
The nucleus basalis of Meynert, senile plaques, and intellectual impairment in schizophrenia
1991 • 50 citations
The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex
2001 • 48 citations
(±)-cis-2-Methylspiro[1,3-oxathiolane-5,3-quinuclidine] Hydrochloride, Hemihydrate (SNI-2011, Cevimeline Hydrochloride) Induces Saliva and Tear Secretions in Rats and Mice: The Role of Muscarinic Acetylcholine Receptors
1998 • 46 citations
Enhanced performance of spatial and visual recognition memory tasks by the selective acetylcholinesterase inhibitor E2020 in rhesus monkeys
1997 • 43 citations
Milameline (CI-979/RU35926): a muscarinic receptor agonist with cognition-activating properties: biochemical and in vivo characterization.
1999 • 43 citations
Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies
1994 • 40 citations
Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man
2001 • 38 citations
Deficits in passive-avoidance learning following atropine in the developing rat
1977 • 31 citations
Minireview: Noncompetitive Agonism at Nicotinic Acetylcholine Receptors; Functional Significance for CNS Signal Transduction
1995 • 31 citations
Pharmacological Alleviation of Combined Cholinergic/Noradrenergic Lesion-Induced Memory Deficits in Rats
1991 • 29 citations
Differential Competition with Cytotoxic Agents: An Approach to Selectivity in Cancer Chemotherapy
1979 • 26 citations
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors
2000 • 19 citations
CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology
2000 • 13 citations
High marker-density analyses of the α7-nicotinic cholinergic receptor subunit (CHRNA7) gene region on chromosome 15q13-q14 and 5′-rage cloning of fragments specific to CHRNA7 or its partial duplication
2000 • 5 citations